We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$344M
AUM Growth
-$23.9M
Cap. Flow
-$31.8M
Cap. Flow %
-9.24%
Top 10 Hldgs %
51.87%
Holding
64
New
18
Increased
3
Reduced
20
Closed
20

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$6.52M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$5.85M
3
JNJ icon
Johnson & Johnson
JNJ
+$4.28M
4
ABBV icon
AbbVie
ABBV
+$4.07M
5
ZBH icon
Zimmer Biomet
ZBH
+$3.96M

Top Sells

Rank Stock Value
1
THC icon
Tenet Healthcare
THC
+$8.87M
2
NVO
Novo Nordisk
NVO
+$6.9M
3
WAT icon
Waters Corp
WAT
+$6.28M
4
GILD icon
Gilead Sciences
GILD
+$5.54M
5
UHS icon
Universal Health Services
UHS
+$4.41M

Sector Composition

Rank Sector Weight
1 Healthcare 48.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBI icon
1
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$25.1M 7.29%
250,000
– –
LLY icon
2
Eli Lilly
LLY
$1.06T
$7.63M 2.22%
10,000
-1,000
-9% -$744K
HCA icon
3
HCA Healthcare
HCA
$89.5B
$7.25M 2.11%
17,000
-8,000
-32% -$3.1M
THC icon
4
Tenet Healthcare
THC
$21.1B
$7.11M 2.07%
35,000
-50,000
-59% -$8.87M
DHR icon
5
Danaher
DHR
$144B
$6.94M 2.02%
35,000
-5,000
-13% -$995K
BSX icon
6
Boston Scientific
BSX
$71.5B
$6.83M 1.99%
70,000
-10,000
-13% -$1.04M
TMO icon
7
Thermo Fisher Scientific
TMO
$220B
$6.79M 1.98%
+14,000
New +$6.52M
HUM icon
8
Humana
HUM
$46.2B
$6.5M 1.89%
25,000
-2,000
-7% -$526K
COR icon
9
Cencora
COR
$61.2B
$6.25M 1.82%
20,000
-5,000
-20% -$1.47M
CAH icon
10
Cardinal Health
CAH
$55.4B
$5.89M 1.71%
37,500
-7,500
-17% -$1.16M
ISRG icon
11
Intuitive Surgical
ISRG
$134B
$5.81M 1.69%
13,000
– –
SNN icon
12
Smith & Nephew
SNN
$12.6B
$5.81M 1.69%
160,000
+20,000
+14% +$690K
UHS icon
13
Universal Health Services
UHS
$10.5B
$5.72M 1.67%
28,000
-24,500
-47% -$4.41M
MDT icon
14
Medtronic
MDT
$112B
$5.71M 1.66%
60,000
-20,000
-25% -$1.84M
VRTX icon
15
Vertex Pharmaceuticals
VRTX
$126B
$5.48M 1.6%
+14,000
New +$5.85M
MCK icon
16
McKesson
MCK
$101B
$5.41M 1.57%
7,000
-6,000
-46% -$4.23M
ABT icon
17
Abbott
ABT
$187B
$5.02M 1.46%
37,500
-1,700
-4% -$223K
SYK icon
18
Stryker
SYK
$130B
$4.81M 1.4%
13,000
-6,000
-32% -$2.32M
SGRY icon
19
Surgery Partners
SGRY
$2.03B
$4.76M 1.39%
220,000
+95,000
+76% +$2.12M
JNJ icon
20
Johnson & Johnson
JNJ
$625B
$4.64M 1.35%
+25,000
New +$4.28M
ABBV icon
21
AbbVie
ABBV
$435B
$4.63M 1.35%
+20,000
New +$4.07M
EHC icon
22
Encompass Health
EHC
$12.4B
$4.45M 1.29%
35,000
+10,000
+40% +$1.19M
A icon
23
Agilent Technologies
A
$41.2B
$4.24M 1.23%
33,000
-12,000
-27% -$1.45M
UNH icon
24
UnitedHealth
UNH
$370B
$4.14M 1.21%
12,000
-3,000
-20% -$907K
CI icon
25
Cigna
CI
$74.6B
$4.04M 1.17%
14,000
-2,500
-15% -$740K
1
2

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
A
AFBI Miami Beach, Florida $131M AUM
SPWM
Schrum Private Wealth Management St. Augustine, Florida $131M AUM 18.38% 1-Year Est. Return

Sivik Global Healthcare's Q3 2025 Portfolio in Review

As of Q3 2025, Sivik Global Healthcare held 64 positions worth $344M, down 6.5% from $368M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Sivik Global Healthcare withdrew a net $31.8M in Q3 2025, closing 20 positions and reducing 20 holdings. Its most notable exit was Novo Nordisk, an estimated $6.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 55% a quarter earlier.

Against the trend, Sivik Global Healthcare opened a new position in Thermo Fisher Scientific worth $6.79M.

  • Sivik Global Healthcare's largest Q3 2025 buy was Thermo Fisher Scientific: 14,000 shares worth $6.79M.
  • Sivik Global Healthcare added most to Surgery Partners in Q3 2025, an estimated $2.12M increase.
  • Sivik Global Healthcare's biggest Q3 2025 reduction was Tenet Healthcare, cutting an estimated $8.87M.
  • Sivik Global Healthcare fully exited Novo Nordisk in Q3 2025, selling an estimated $6.9M.
  • Sivik Global Healthcare's ten largest holdings make up 52% of its $344M portfolio in Q3 2025.
  • Sivik Global Healthcare opened 18 new positions and closed 20 in Q3 2025.
  • Sivik Global Healthcare's portfolio value fell 6.5% quarter-over-quarter to $344M.

Based on Sivik Global Healthcare's 13F filing for Q3 2025, filed 23 Oct 2025.